Table 4. Studies on TIL-T for colorectal cancer.
| NCT number | Disease type | N | Phase | Status | First posted | Last update posted |
|---|---|---|---|---|---|---|
| NCT01174121 | Metastatic colorectal cancer | 332 | II | Recruiting | 2010-08-03 | 2022-09-08 |
| NCT03610490 | Metastatic colorectal adenocarcinoma | 27 | II | Active, not recruiting | 2018-08-01 | 2021-11-10 |
| NCT03904537 | Colorectal cancer stage III | 20 | I/II | Unknown status | 2019-04-05 | 2019-04-05 |
| NCT03935893 | Colorectal cancer | 10 | II | Recruiting | 2019-05-02 | 2022-07-22 |
| NCT04426669 | Colorectal cancer | 20 | I/II | Recruiting | 2020-06-11 | 2021-08-23 |
| NCT04842812 | Colorectal cancer | 40 | I | Recruiting | 2021-04-13 | 2021-04-13 |
NCT, National Clinical Trial; TIL, tumor-infiltrating lymphocyte.